SUSTAMINE Trademark

Trademark Overview


On Wednesday, October 18, 2023, a trademark application was filed for SUSTAMINE with the United States Patent and Trademark Office. The USPTO has given the SUSTAMINE trademark a serial number of 98228979. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, June 10, 2024. This trademark is owned by KYOWA HAKKO BIO CO., LTD.. The SUSTAMINE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

L-Alanyl-L-Glutamine for culture medium supplements or culture medium additives for medical or veterinary use; Dietary supplements

L-Alanyl-L-Glutamine for use in the manufacture of pharmaceuticals, cosmetics, foods and dietary supplements; Amino acid peptides for use in the manufacture of pharmaceuticals, cosmetics, foods and dietary supplements; Chemical additives for use in the manufacture of pharmaceuticals, cosmetics, foods and dietary supplements; L-Alanyl-L-Glutamine for culture medium supplements or culture medium additives other than for medical or veterinary use; Chemicals for use in the manufacture of pharmaceuticals, cosmetics, foods and dietary supplements
sustamine

General Information


Serial Number98228979
Word MarkSUSTAMINE
Filing DateWednesday, October 18, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, June 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesL-Alanyl-L-Glutamine for culture medium supplements or culture medium additives for medical or veterinary use; Dietary supplements
Goods and ServicesL-Alanyl-L-Glutamine for use in the manufacture of pharmaceuticals, cosmetics, foods and dietary supplements; Amino acid peptides for use in the manufacture of pharmaceuticals, cosmetics, foods and dietary supplements; Chemical additives for use in the manufacture of pharmaceuticals, cosmetics, foods and dietary supplements; L-Alanyl-L-Glutamine for culture medium supplements or culture medium additives other than for medical or veterinary use; Chemicals for use in the manufacture of pharmaceuticals, cosmetics, foods and dietary supplements

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, October 24, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKYOWA HAKKO BIO CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 100-8185
JP

Trademark Events


Event DateEvent Description
Saturday, October 21, 2023NEW APPLICATION ENTERED
Tuesday, October 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 31, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, November 1, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, March 21, 2024ASSIGNED TO LIE
Thursday, March 21, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, June 10, 2024NON-FINAL ACTION E-MAILED
Monday, June 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 10, 2024NON-FINAL ACTION WRITTEN
Tuesday, June 4, 2024ASSIGNED TO EXAMINER